Published online before print April 3, 2003, doi: 10.1161/01.RES.0000070111.98158.6C
© 2003 American Heart Association, Inc.
Molecular Medicine |
CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation
From the Portex (D.P.I., M.J.P.), Immunobiology (R.E.C.), and Infectious Diseases and Microbiology (N.J.K.) Units, Institute of Child Health, London, England; and Leukocyte Adhesion Laboratory (A.M.), Cancer Research UK London Research Institute, London, England.
Correspondence to David Inwald, Portex Anaesthesia, Intensive Therapy and Respiratory Unit, Institute of Child Health, 30 Guilford St, London WC1N 1EH, England. E-mail D.Inwald{at}ich.ucl.ac.uk
CD40 is a 48-kDa phosphorylated transmembrane glycoprotein belonging to the TNF receptor superfamily. CD40 has been demonstrated on a range of cell types, and it has an important role in adaptive immunity and inflammation. CD40 has recently been described on platelets but platelet activation by CD40 has not been described. In the present study, we use flow cytometry and immunoblotting to confirm that platelets constitutively express surface CD40. CD40 mRNA was undetectable, suggesting that the protein is synthesized early in platelet differentiation by megakaryocytes. Ligation of platelet CD40 with recombinant soluble CD40L trimer (sCD40LT) caused increased platelet CD62P expression, 
-granule and dense granule release, and the classical morphological changes associated with platelet activation. CD40 ligation also caused ß3 integrin activation, although this was not accompanied by platelet aggregation. These actions were abrogated by the CD40L blocking antibody TRAP-1 and the CD40 blocking antibodies M2 and M3, showing that activation was mediated by CD40L binding to platelet CD40. ß3 integrin blockade with eptifibatide had no effect, indicating that outside-in signaling via IIbß3 was not contributing to these CD40-mediated effects. CD40 ligation led to enhanced platelet-leukocyte adhesion, which is important in the recruitment of leukocytes to sites of thrombosis or inflammation. Our results support a role for CD40-mediated platelet activation in thrombosis, inflammation, and atherosclerosis.
Key Words: CD40/CD40L • platelets • atherosclerosis • inflammation • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  C. R. Gilson, Z. Milas, S. Gangappa, D. Hollenbaugh, T. C. Pearson, M. L. Ford, and C. P. Larsen Anti-CD40 Monoclonal Antibody Synergizes with CTLA4-Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation J. Immunol., August 1, 2009; 183(3): 1625 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Stokes, L. Calahan, C. M. Hamric, J. M. Russell, and D. N. Granger CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H689 - H697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pignatelli, R. Cangemi, A. Celestini, R. Carnevale, L. Polimeni, A. Martini, D. Ferro, L. Loffredo, and F. Violi Tumour necrosis factor {alpha} upregulates platelet CD40L in patients with heart failure Cardiovasc Res, June 1, 2008; 78(3): 515 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li Platelet-lymphocyte cross-talk J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, J. M. Sanders, M. H. Bevard, Z. Sun, J. W. Chumley, E. V. Galkina, K. Ley, and I. J. Sarembock CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury Am. J. Pathol., April 1, 2008; 172(4): 1141 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Brass, L. Zhu, and T. J. Stalker Novel Therapeutic Targets at the Platelet Vascular Interface Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s43 - s50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hammwohner, A. Ittenson, J. Dierkes, A. Bukowska, H. U. Klein, U. Lendeckel, and A. Goette Platelet Expression of CD40/CD40 Ligand and Its Relation to Inflammatory Markers and Adhesion Molecules in Patients with Atrial Fibrillation Experimental Biology and Medicine, April 1, 2007; 232(4): 581 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-K. L. Robertson and G. K Hansson T Cells in Atherogenesis: For Better or For Worse? Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2421 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Khan, M. R. Kelher, J. M. Heal, N. Blumberg, L. K. Boshkov, R. Phipps, K. F. Gettings, N. J. McLaughlin, and C. C. Silliman Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury Blood, October 1, 2006; 108(7): 2455 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Geraldes, S. Gagnon, S. Hadjadj, Y. Merhi, M. G. Sirois, I. Cloutier, and J.-F. Tanguay Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: An ER{alpha}-mediated pathway Cardiovasc Res, August 1, 2006; 71(3): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Lee, K. I. Ataga, E. P. Orringer, D. R. Phillips, and L. V. Parise Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia: Potential Role for Platelet-Mediated Inflammation Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1626 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Ng, K. Li, T. F. Leung, R. P.O. Wong, G. Li, K. M. Chui, E. Wong, F. W.T. Cheng, and T. F. Fok Early Prediction of Sepsis-Induced Disseminated Intravascular Coagulation with Interleukin-10, Interleukin-6, and RANTES in Preterm Infants Clin. Chem., June 1, 2006; 52(6): 1181 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fujimi, M. P. MacConmara, A. A. Maung, Y. Zang, J. A. Mannick, J. A. Lederer, and P. H. Lapchak Platelet depletion in mice increases mortality after thermal injury Blood, June 1, 2006; 107(11): 4399 - 4406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Armstrong, D. A. Morrow, and M. S. Sabatine Inflammatory Biomarkers in Acute Coronary Syndromes: Part IV: Matrix Metalloproteinases and Biomarkers of Platelet Activation Circulation, March 7, 2006; 113(9): e382 - e385. [Full Text] [PDF]
|
|
|
|
|
|
T. Vowinkel, K. C. Wood, K. Y. Stokes, J. Russell, C. F. Krieglstein, and D. N. Granger Differential expression and regulation of murine CD40 in regional vascular beds Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H631 - H639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Santilli, G. Davi, A. Consoli, F. Cipollone, A. Mezzetti, A. Falco, T. Taraborelli, E. Devangelio, G. Ciabattoni, S. Basili, et al. Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., January 17, 2006; 47(2): 391 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chakrabarti, S. Varghese, O. Vitseva, K. Tanriverdi, and J. E. Freedman CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2428 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A.Lopez The SLAM family of receptors: new players in platelet aggregation Blood, November 1, 2005; 106(9): 2929 - 2930. [Full Text] [PDF]
|
|
|
|
|
|
U. Bavendiek, A. Zirlik, S. LaClair, L. MacFarlane, P. Libby, and U. Schonbeck Atherogenesis in Mice Does Not Require CD40 Ligand From Bone Marrow-Derived Cells Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion Circulation, April 5, 2005; 111(13): 1690 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Akbiyik, D. M. Ray, K. F. Gettings, N. Blumberg, C. W. Francis, and R. P. Phipps Human bone marrow megakaryocytes and platelets express PPAR{gamma}, and PPAR{gamma} agonists blunt platelet release of CD40 ligand and thromboxanes Blood, September 1, 2004; 104(5): 1361 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Aukrust, J. K. Damas, and N. O. Solum Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2326 - 2328. [Full Text] [PDF]
|
|
|
|
|
|
S. Danese, C. de la Motte, B. M. R. Reyes, M. Sans, A. D. Levine, and C. Fiocchi Cutting Edge: T Cells Trigger CD40-Dependent Platelet Activation and Granular RANTES Release: A Novel Pathway for Immune Response Amplification J. Immunol., February 15, 2004; 172(4): 2011 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kaufman, P. J. Sime, and R. P. Phipps Expression of CD154 (CD40 Ligand) by Human Lung Fibroblasts: Differential Regulation by IFN-{gamma} and IL-13, and Implications for Fibrosis J. Immunol., February 1, 2004; 172(3): 1862 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schafer, C. Schulz, M. Eigenthaler, D. Fraccarollo, A. Kobsar, M. Gawaz, G. Ertl, U. Walter, and J. Bauersachs Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion Blood, January 15, 2004; 103(2): 407 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Szmitko, C.-H. Wang, R. D. Weisel, J. R. de Almeida, T. J. Anderson, and S. Verma New Markers of Inflammation and Endothelial Cell Activation: Part I Circulation, October 21, 2003; 108(16): 1917 - 1923. [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. S. Prasad, P. Andre, M. He, M. Bao, J. Manganello, and D. R. Phillips Soluble CD40 ligand induces {beta}3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling PNAS, October 14, 2003; 100(21): 12367 - 12371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Freedman CD40-CD40L and Platelet Function: Beyond Hemostasis Circ. Res., May 16, 2003; 92(9): 944 - 946. [Full Text] [PDF]
|
|